Hs-CRP, as a sensitive indicator of inflammation, has been proved to be not only the independent risk factor of cardiovascular disease but also mediator of atherosclerosis through IL-1-to-IL-6-to-CRP signalling pathway by CANTOS trial (8). Here, CRP is linked to cardiovascular disorder.